Related Experiment Video
Updated: Jul 30, 2026

13:21
In Vivo Biosensor Tracks Non-apoptotic Caspase Activity in Drosophila
Published on: November 27, 2016
Regulation of apoptosis by vasoactive peptides
G S Filippatos1, N Gangopadhyay, O Lalude
1Second Division of Cardiology, Evangelismos General Hospital, GR-11526 Athens, Greece.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|September 15, 2001
Summary
Vasoactive peptides regulate cell death (apoptosis) in various ways, influencing neurotransmission and cell proliferation. Research highlights their roles in pulmonary physiology, with specific focus on endothelin and angiotensin II.
Area of Science:
- Physiology
- Molecular Biology
- Cell Biology
Background:
- Vasoactive peptides, initially known for hemodynamic effects, possess diverse roles including neurotransmission, endocrine functions, and cell proliferation regulation.
- Emerging evidence indicates vasoactive peptides can modulate apoptosis, either promoting or inhibiting cell death.
- The regulatory roles of endothelin, angiotensin II, vasoactive intestinal peptide, atrial natriuretic peptide, and adrenomedullin in apoptosis are increasingly recognized.
Purpose of the Study:
- To review the current evidence on vasoactive peptides' roles in apoptosis.
- To examine the specific mechanisms by which key vasoactive peptides regulate apoptosis.
- To discuss the implications of these peptides in pulmonary physiology.
Main Methods:
- Literature review of studies investigating vasoactive peptides and apoptosis.
- Analysis of experimental data on peptide-specific apoptosis regulation.
- Synthesis of findings regarding target cell specificity and pulmonary relevance.
Main Results:
- Vasoactive peptides exhibit varied effects on apoptosis, dependent on the specific peptide and target cell type.
- Endothelin, angiotensin II, vasoactive intestinal peptide, atrial natriuretic peptide, and adrenomedullin demonstrate significant regulatory activity in apoptosis.
- These peptides show distinct target cell specificities within various tissues, including the lungs.
Conclusions:
- Vasoactive peptides are critical regulators of apoptosis with significant implications for pulmonary physiology.
- Understanding peptide-specific apoptosis modulation is crucial for therapeutic development.
- Further research is warranted to elucidate the full spectrum of vasoactive peptide functions in cell death and disease.
Related Concept Videos
Apoptosis
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Caspases
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Phagocytosis of Apoptotic Cells
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...

